Response to gefitinib in advanced non-small cell lung cancer patients (NSCLC) with rare epidermal growth factor (EGFR) mutations—serbian experience 2011-2014.

Zarić, Bojan; Perin, Branislav; Radosavljevic D; Jovanovic D; Spasic J; Cavic M; Jankovic R; Velinovic M.

Results

eNauka > Results > Response to gefitinib in advanced non-small cell lung cancer patients (NSCLC) with rare epidermal growth factor (EGFR) mutations—serbian experience 2011-2014.

Title:	Response to gefitinib in advanced non-small cell lung cancer patients (NSCLC) with rare epidermal growth factor (EGFR) mutations—serbian experience 2011-2014.
Authors:	Zarić, Bojan ; Perin, Branislav ; Radosavljevic D; Jovanovic D; Spasic J; Cavic M; Jankovic R; Velinovic M.
Issue Date:	2014
Publication:	Translational Lung Cancer Research
ISSN:	2218-6751 Translational Lung Cancer Research Search Idenfier
Publisher:	Translational Lung Cancer Research / CELCC, Austria
Type:	Conference Paper
Collation:	vol. 5 br. 3 str. 21-21
URI:	https://enauka.gov.rs/handle/123456789/522320
Metadata source:	Migrirano iz RIS podataka
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM